top of page

Board Members

MJ Oktober 23_edited.png
Anders Hedlund
AllanAsp_edited.png
Lars Picture_edited.png
Ulf Picture_edited.png

Mats Johnson, Chairman of the Board

Mats has more than 40 years of experience in the life science area in biotech supply, drug discovery, and genetic modifications of plants, mainly in different business positions but also from R&D with the companies Pharmacia Biotech, Amersham Biosciences, SweTree Technologies, and Bio-Works Technologies. In the last two companies, Mats was CEO, all-in-all, for almost 15 years. SweTree was brought to profitability and Bio-Works was built to an IPO, with relevant industrial structures and global market access. Mats has during the last 15 years been instrumental in finding financing of around 500 MSEK for many companies such as SweTree, its spin-outs, and Bio-Works.

Anders Hedlund, Board member

Anders is a full-time investor and CEO of Nolsterby Invest, a family office focused on investments in the healthcare sector. He has a background in finance and investment banking and with more than ten years of experience in the healthcare sector.

Before joining Nolsterby Invest in 2021, Anders worked as an equity analyst covering small- and medium enterprises in medtech and biotech. Before that, Anders worked in various finance roles in the GE Healthcare group.

He holds a Master's degree in Business Economy from Uppsala University and has also studied Human Physiology at Karolinska Institutet.”

Allan Asp, Board member

With a background in chemistry and molecular biology, Allan Asp worked in the Swedish pharma/biotech industry for almost 25 years (e.g. Kabi Biopharma, Pharmacia Biotech, Pyrosequencing, and Alphahelix), before joining Almi Invest as Investment Manager in 2008

Lars Holmberg, Board member and co-founder

Lars has extensive expertise and deep know-how in peptide and oligonucleotide chemistry. Lars invented the first large-scale flowthrough column technology instruments for oligonucleotide production while at Pharmacia in the 1990s. Lars worked for GE Healthcare commercializing the instruments for many years until starting PeptiSystems in 2014. Lars was the CEO of PeptiSystems until 2023. Lars has a Ph.D. in Carbohydrate Chemistry.

Ulf Tedebark, Board member and co-founder

Ulf has 25+ years of experience in the life science areas and worked for 15 years at GE Healthcare in R&D, project management, and product support. He specializes in polymer supports, oligonucleotide and peptide synthesis, and biomolecule conjugate synthesis. Ulf has 7 patents/patent applications and has published more than 20 scientific publications in peer-reviewed journals. Ulf has a Ph.D. in Oligosaccharide Synthesis.

bottom of page